drugset / Trial / NCT07599865

Periprosthetic Joint Infection Bubble Study

NCT07599865

RandomizedSingle-groupOpen-labelTreatment

Summary

Patients with an infected knee replacement will receive their standard of care surgical treatment of the infection, with and without additional ultrasound microbubble treatment (randomly divided 50/50 in the active and control groups). Subjects in the active group will receive a local bolus injection of antibiotics and ultrasound-active microbubbles within 24 hours of their revision surgery. The fundamental hypothesis is that a decrease in re-infection rates of at least 24% can be achieved in the active group relative to controls.

Timeline

Start
2026-06
Primary completion
2028-06
Completion
2030-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Definity Diagnostic / imaging agent Other